 |
|
|
 |
|
|
|
 |
2011.02.10
|
Conclusion of Licensing Agreement with Pastorus Pharma, LLC.
|
[PDF]
 |
 |
|
|
|
|
2010.08.19
|
Results of a Meeting with the US Food and Drug Administration (FDA) Concerning the Development of Intranasal Granisetron; Planning for a Phase 3 Study to Improve Patient Quality of Life (QOL)
|
[PDF]
|
|
2010.08.11
|
Intranasal Zolmitriptan: Clinical Study of Rapid Acting Migraine Drug
- Preparations Underway for US Phase 1 Clinical Study -
|
[PDF]
|
|
2010.05.12
|
Research Progress on TR-Flu, an Intranasal Flu Vaccine in Dry Powder Form
(First Report)
|
[PDF]
|
 |
|
|
|
|
2009.11.27
|
Exhibition at the Japanese Society for the Study of Xenobiotics Annual Meeting
|
|
|
2009.09.03
|
Development of Nasal Zolmitriptan Product for Migraine
|
[PDF]
|
|
2009.08.03
|
Results of Phase II Clinical Trial for Nasal Granisetron (US)
|
[PDF]
|
|
2009.08.01
|
Translational Research, Ltd. (TRL) was merged into the parent company (SNBL,
Ltd.) and became Translational Research Division.
|
|
|
2009.07.06
|
Luncheon Seminar and Exhibition at the Japanese Society of Toxicology
|
|
|
|
2008
2007
2006
2004 |
|
